News Quantified

ORGO – organogenesis holdings inc. - class a (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Organogenesis (NASDAQ:ORGO) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $9.00 price target on the stock.

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Organogenesis (NASDAQ:ORGO) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $9.00 price target on the stock.

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain [Yahoo! Finance]

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

-42.7%

MISS

102.9%

BEAT

102.9%

BEAT

102.9%

BEAT

Form 4 Organogenesis Holdings For: Dec 16 Filed by: NUSSDORF GLENN H

Form 144 Organogenesis Holdings Filed by: NUSSDORF GLENN H

Form 4 Organogenesis Holdings For: Nov 24 Filed by: NUSSDORF GLENN H

Form 144 Organogenesis Holdings Filed by: NUSSDORF GLENN H

Form 144 Organogenesis Holdings Filed by: NUSSDORF GLENN H

Top News Gainers

3/12 Organogenesis Holdings Inc (NASDAQ: ORGO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.25 price target on the stock. 33.2%

8/16 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 29.1%

3/16 Form 4 Organogenesis Holdings For: Mar 12 Filed by: Burgstahler David F 18.4%

9/5 Form 4 Organogenesis Holdings For: Sep 03 Filed by: Dean Thompson 15.1%

9/20 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 14.7%

4/16 Form 4 Organogenesis Holdings For: Oct 01 Filed by: Grow Brian 12.2%

9/10 Form 4 Organogenesis Holdings For: Sep 06 Filed by: GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 11.5%

11/12 Organogenesis Holdings Inc (ORGO) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.6%

8/31 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.8%

4/24 Form 4 Organogenesis Holdings For: Apr 22 Filed by: Leibowitz Arthur S 7.7%

Top News Decliners

11/21 Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock -22.2%

3/18 Organogenesis Holdings Inc (NASDAQ: ORGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -18.9%

3/9 Form 10-K Organogenesis Holdings For: Dec 31 -18.3%

8/19 Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants -14.8%

4/1 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -12.0%

7/12 Form PRE 14A Organogenesis Holdings For: Jul 12 -11.9%

9/9 Form SC 13D/A Organogenesis Holdings Filed by: Avista Acquisition Corp. -8.5%

3/16 Form 8-K Organogenesis Holdings For: Mar 10 -8.2%

7/22 Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation -7.8%

7/16 Form SC TO-C Organogenesis Holdings Filed by: Organogenesis Holdings Inc. -7.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day